Deborah White

Professor

  • Director, Cancer Program, Cancer
  • 3725 Citations
  • 26 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Prof White is the Director of Cancer Research and Deputy Cancer Theme Leader at the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide. She is a Senior Principal Research Fellow with SAHMRI, and a Professor in Medicine, Paediatrics and Medical Sciences at the University of Adelaide and Health Sciences at Uni SA.

 

Prof White’s research focus is in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia and the Cancer Council SA (CCSA). Professor White has presented more than 150 papers at scientific meetings, and authored more than 85 scientific publications on CML and ALL, as well as being an inventor on several patents.

 

Professor White is the lead investigator of the ALL Stream of Australian Genomics, and SA scientific lead for Zero Children’s Cancer. She is an active member of the National Health & Medical Research Council (NHMRC) being a member of the NHMRC Academy, the Translational Research Program Advisory Committee, and the Women in Health Science Executive Committee. She is a member of the Editorial Board for Cancer Letters.

 

In 2014 she was recognised as the Australian Society for Medical Research (ASMR) Leading Light for her Medical Research and in 2016 was awarded the University of Adelaide James McWha medal.

 

Education/Academic qualification

Fellowship of the Royal College of Pathologists of Australia, Royal College of Pathologists of Australasia

PhD, University of Adelaide

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Ross, D. M., Pagani, I., Irani, Y., Clarson, J., Gray, T., Dang, Y., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D. S., White, D., Branford, S., Hughes, T. & Yong, A., 1 Jan 2019, In : British Journal of Haematology.

Research output: Contribution to journalLetter

3 Citations (Scopus)

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Pagani, I. S., Dang, P., Kommers, I. O., Goyne, J. M., Nicola, M., Saunders, V. A., Braley, J., White, D. L., Yeung, D. T., Branford, S., Hughes, T. P. & Ross, D. M., 30 Nov 2018, In : Haematologica. 103, 12, p. 2026-2032 7 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten

Nair, S. S., Luu, P. L., Qu, W., Maddugoda, M., Huschtscha, L., Reddel, R., Chenevix-Trench, G., Toso, M., Kench, J. G., Horvath, L. G., Hayes, V. M., Stricker, P. D., Hughes, T. P., White, D. L., Rasko, J. E. J., Wong, J. J. L. & Clark, S. J., 28 May 2018, In : Epigenetics and Chromatin. 11, 1, 24.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Branford, S., Wang, P., Yeung, D., Thomson, D., Purins, A., Wadham, C., Shahrin, N. H., Marum, J. E., Nataren, N., Parker, W. T., Geoghegan, J., Feng, J., Shanmuganathan, N., Mueller, M. C., Dietz, C., Stangl, D., Donaldson, Z., Altamura, H., Georgievski, J., Braley, J. & 13 othersBrown, A., Hahn, C., Walker, I., Kim, S. H., Choi, S. Y., Park, S. H., Kim, D. W., White, D., Yong, A., Ross, D. M., Scott, H. S., Schreiber, A. W. & Hughes, T., 30 Aug 2018, In : Blood. 132, 9, p. 948-961 14 p.

Research output: Contribution to journalArticle